ConductScience.org, home

Library / Trials

Cognitive Training Video Game to Target Subclinical Depressive Symptoms in Youth

NCT05697627, Not applicable, Completed, University of Michigan; results first posted 2025-06-18

Trial 12

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleCognitive Training Video Game to Target Subclinical Depressive Symptoms in YouthClinicalTrials.gov
NCT numberNCT05697627ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment31 participants, actualClinicalTrials.gov
Lead sponsorUniversity of MichiganClinicalTrials.gov
ConditionsDepression, Subclinical Depressive SymptomsClinicalTrials.gov
InterventionsComputerized cognitive training (CCT) using EndeavorRxClinicalTrials.gov
First posted2023-01-26ClinicalTrials.gov
Last updated2025-06-18ClinicalTrials.gov
Results first posted2025-06-18ClinicalTrials.gov
Limitations and caveatsThis was a small-scale study, and there was no randomization or control intervention provided.ClinicalTrials.gov

Registered outcomes 13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange in Depressive Symptoms as Measured by Children's Depression Inventory (CDI)Baseline and approximately 5 weeks after
The CDI was a self-report, 27 item scale used to measure depressive symptoms. Total scores on the CDI ranged from 0 (no depressive symptoms) to 54 (extremely severe depressive symptoms). Higher scores indicated worse depressive symptoms. CDI scores were collected from participants at three timepoints: 1) baseline, 2) approximately 5 weeks after baseline, and 3) up to 4 months after baseline. Results reflect CDI scores collected at the first and second timepoints.
ClinicalTrials.gov
PrimaryChange in Depressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R)Baseline and approximately 5 weeks after
The CDRS-R is a clinician-administered tool used to assess the severity of depression in children and adolescents based on a 17-item scale of depressive symptoms. Total raw scores on this scale range from 17-113, with 17 indicating no or minimal depressive symptoms and 113 indicating extremely severe symptoms of depression. CDRS-R scores were collected from participants at three timepoints: 1) baseline, 2) approximately 5 weeks after baseline, and 3) up to 4 months after baseline. Results reflect CDRS-R scores collected at the first and second timepoints.
ClinicalTrials.gov
PrimaryChange in Cognitive Control Capacity - Overall Reaction Time (RT) StroopBaseline and approximately 5 weeks after
The Stroop task assesses cognitive control and emotion regulation over emotional information processing by measuring how quickly individuals name the ink color of words that are emotionally-charged or neutral. For this measure, lower scores indicated better performance, i.e., better cognitive control and emotion regulation. Results reflect the average reaction time across all trials of the Stroop task that participants completed.
ClinicalTrials.gov
PrimaryChange in Cognitive Control Capacity - Conflict RT StroopBaseline and approximately 5 weeks after
The Stroop task assesses cognitive control and emotion regulation over emotional information processing by measuring how quickly individuals name the ink color of words that are emotionally-charged or neutral. For this measure, lower scores indicated better performance, i.e., better cognitive control and emotion regulation. Results reflect the difference in the reaction time between incongruent trials and congruent trials on the Stroop task.
ClinicalTrials.gov
PrimaryChange in Cognitive Control Capacity - Overall RT FlankerBaseline and approximately 5 weeks after
The Flanker task is a psychological experiment that assesses a person's ability to focus on a target stimulus while ignoring distracting stimuli. For this measure, higher scores indicate better performance. Results reflect the average reaction time across all trials of the Flanker task that participants completed at this timepoint.
ClinicalTrials.gov
PrimaryChange in Cognitive Control Capacity - Conflict RT FlankerBaseline and approximately 5 weeks after
The Flanker task is a psychological experiment that assesses a person's ability to focus on a target stimulus while ignoring distracting stimuli. For this measure, higher scores indicate better performance. Results reflect the difference in the reaction time between incongruent trials and congruent trials of the Flanker task.
ClinicalTrials.gov
SecondaryChildren's Depression Inventory (CDI) at Third TimepointUp to 4 months
The CDI was a self-report, 27 item scale used to measure depressive symptoms. Total scores on the CDI ranged from 0 (no depressive symptoms) to 54 (extremely severe depressive symptoms). Higher scores indicated worse depressive symptoms. CDI scores were collected from participants at three timepoints: 1) baseline, 2) approximately 5 weeks after baseline, and 3) up to 4 months after baseline. Results reflect CDI scores collected at the third timepoint.
ClinicalTrials.gov
SecondaryDepressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R) at Third TimepointUp to 4 months
The CDRS-R is a clinician-administered tool used to assess the severity of depression in children and adolescents based on a 17-item scale of depressive symptoms. Total raw scores on this scale range from 17-113, with 17 indicating no or minimal depressive symptoms and 113 indicating extremely severe symptoms of depression. CDRS-R scores were collected from participants at three timepoints: 1) baseline, 2) approximately 5 weeks after baseline, and 3) up to 4 months after baseline. Results reflect CDRS-R scores collected at the third timepoint.
ClinicalTrials.gov
SecondaryCognitive Control Capacity - Overall Reaction Time (RT) StroopUp to 4 months
The Stroop task assesses cognitive control and emotion regulation over emotional information processing by measuring how quickly individuals name the ink color of words that are emotionally-charged or neutral. For this measure, lower scores indicated better performance, i.e., better cognitive control and emotion regulation. Results reflect the average reaction time across all trials of the Stroop task that participants completed at this timepoint.
ClinicalTrials.gov
SecondaryCognitive Control Capacity - Conflict RT StroopUp to 4 months
The Stroop task assesses cognitive control and emotion regulation over emotional information processing by measuring how quickly individuals name the ink color of words that are emotionally-charged or neutral. For this measure, lower scores indicated better performance, i.e., better cognitive control and emotion regulation. Results reflect the difference in the reaction time between incongruent trials and congruent trials on the Stroop task.
ClinicalTrials.gov
SecondaryCognitive Control Capacity - Overall RT FlankerUp to 4 months
The Flanker task is a psychological experiment that assesses a person's ability to focus on a target stimulus while ignoring distracting stimuli. For this measure, higher scores indicate better performance. Results reflect the average reaction time across all trials of the Flanker task that participants completed at this timepoint.
ClinicalTrials.gov
SecondaryCognitive Control Capacity - Conflict RT FlankerUp to 4 months
The Flanker task is a psychological experiment that assesses a person's ability to focus on a target stimulus while ignoring distracting stimuli. For this measure, higher scores indicate better performance. Results reflect the difference in the reaction time between incongruent trials and congruent trials on the Flanker task.
ClinicalTrials.gov
OtherFeasibility/Acceptability and Experimental OutcomeUp to 4 months
Outcome measures that indicate how much the video game was played and acceptability of the game as indicated by self-report ratings. Includes: gameplay metrics from the video game (total amount of missions completed across the 4-weeks of the intervention), Endeavor Satisfaction Survey Scores (Scale 1-5 (3 is neutral) on each item; parent and child report), and depressive symptoms at baseline (Children's Depression Inventory).
ClinicalTrials.gov

Outcomes 13

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource
PRIMARYChange in Depressive Symptoms as Measured by Children's Depression Inventory (CDI)Baseline and approximately 5 weeks afterOne participant dropped out of the study before the follow-up assessment.score on a scaleMEANClinicalTrials.gov
PRIMARYChange in Depressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R)Baseline and approximately 5 weeks afterOne participant dropped out of the study before the 5-week assessment.score on a scaleMEANClinicalTrials.gov
PRIMARYChange in Cognitive Control Capacity - Overall Reaction Time (RT) StroopBaseline and approximately 5 weeks after1 person did not complete the baseline cognitive assessment and also withdrew prior to follow-up assessment.millisecondsMEANClinicalTrials.gov
PRIMARYChange in Cognitive Control Capacity - Conflict RT StroopBaseline and approximately 5 weeks after1 person did not complete the baseline cognitive assessment and also withdrew prior to follow-up assessment.millisecondsMEANClinicalTrials.gov
PRIMARYChange in Cognitive Control Capacity - Overall RT FlankerBaseline and approximately 5 weeks after
Only 19 participants completed any of the cognitive tasks at baseline or follow up. From the 19, 2 participants at pre-intervention did not complete the Flanker task. From the 19, 1 participant at post-intervention did not complete the Flanker task.
millisecondsMEANClinicalTrials.gov
PRIMARYChange in Cognitive Control Capacity - Conflict RT FlankerBaseline and approximately 5 weeks after
Only 19 participants completed any of the cognitive tasks at baseline or follow up. From the 19, 2 participants at pre-intervention did not complete the Flanker task. From the 19, 1 participant at post-intervention did not complete the Flanker task.
millisecondsMEANClinicalTrials.gov
SECONDARYChildren's Depression Inventory (CDI) at Third TimepointUp to 4 monthsThe third timepoint was offered as optional to participants and then eventually removed from the protocol altogether. 10 participants returned and completed the CDI at the optional third time point.score on a scaleMEANClinicalTrials.gov
SECONDARYDepressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R) at Third TimepointUp to 4 monthsThe third timepoint was offered as optional to participants and then eventually removed from the protocol altogether. 11 participants returned to complete the CDRS-R for the optional third timepoint.score on a scaleMEANClinicalTrials.gov
SECONDARYCognitive Control Capacity - Overall Reaction Time (RT) StroopUp to 4 months
The third timepoint was offered as optional to participants and then eventually removed from the protocol altogether. 11 participants completed the third timepoint assessment, and 6 participants completed the cognitive tasks at this timepoint (including Stroop).
millisecondsMEANClinicalTrials.gov
SECONDARYCognitive Control Capacity - Conflict RT StroopUp to 4 months
The third timepoint was offered as optional to participants and then eventually removed from the protocol altogether. 11 participants completed the third timepoint assessment, and 6 participants completed the cognitive tasks at this timepoint (including Stroop).
millisecondsMEANClinicalTrials.gov
SECONDARYCognitive Control Capacity - Overall RT FlankerUp to 4 months
The third timepoint was offered as optional to participants and then eventually removed from the protocol altogether. 11 participants completed the third timepoint assessment, and 6 participants completed the cognitive tasks at this timepoint (including Flanker).
millisecondsMEANClinicalTrials.gov
SECONDARYCognitive Control Capacity - Conflict RT FlankerUp to 4 months
The third timepoint was offered as optional to participants and then eventually removed from the protocol altogether. 11 participants completed the third timepoint assessment, and 6 participants completed the cognitive tasks at this timepoint (including Flanker).
millisecondsMEANClinicalTrials.gov
OTHER_PRE_SPECIFIEDFeasibility/Acceptability and Experimental OutcomeUp to 4 monthsClinicalTrials.gov

Results by group 18

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource
Change in Depressive Symptoms as Measured by Children's Depression Inventory (CDI)Computerized Cognitive Training (CCT) Using EndeavorRxBaseline CDI scores8.85Standard Deviation 3.65score on a scaleClinicalTrials.gov
Change in Depressive Symptoms as Measured by Children's Depression Inventory (CDI)Computerized Cognitive Training (CCT) Using EndeavorRxApproximately 5 weeks5.84Standard Deviation 4.37score on a scaleClinicalTrials.gov
Change in Depressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R)Computerized Cognitive Training (CCT) Using EndeavorRxBaseline - Raw CDRS-R scores30.00Standard Deviation 5.69score on a scaleClinicalTrials.gov
Change in Depressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R)Computerized Cognitive Training (CCT) Using EndeavorRxApproximately 5 weeks - Raw CDRS-R scores24.05Standard Deviation 3.29score on a scaleClinicalTrials.gov
Change in Cognitive Control Capacity - Overall Reaction Time (RT) StroopComputerized Cognitive Training (CCT) Using EndeavorRxOverall RT on Stroop Task pre-intervention1019.44Standard Deviation 131.07millisecondsClinicalTrials.gov
Change in Cognitive Control Capacity - Overall Reaction Time (RT) StroopComputerized Cognitive Training (CCT) Using EndeavorRxOverall RT on Stroop Task post-intervention1018.28Standard Deviation 140.31millisecondsClinicalTrials.gov
Change in Cognitive Control Capacity - Conflict RT StroopComputerized Cognitive Training (CCT) Using EndeavorRxConflict RT (Incongruent Trial RT - Congruent Trial RT) on Stroop Task pre-intervention65.95Standard Deviation 58.60millisecondsClinicalTrials.gov
Change in Cognitive Control Capacity - Conflict RT StroopComputerized Cognitive Training (CCT) Using EndeavorRxConflict RT (Incongruent Trial RT - Congruent Trial RT) on Stroop Task post-intervention62.32Standard Deviation 96.70millisecondsClinicalTrials.gov
Change in Cognitive Control Capacity - Overall RT FlankerComputerized Cognitive Training (CCT) Using EndeavorRxOverall RT on Flanker Task pre-intervention785.93Standard Deviation 266.25millisecondsClinicalTrials.gov
Change in Cognitive Control Capacity - Overall RT FlankerComputerized Cognitive Training (CCT) Using EndeavorRxOverall RT on Flanker Task post-intervention778.62Standard Deviation 435.33millisecondsClinicalTrials.gov
Change in Cognitive Control Capacity - Conflict RT FlankerComputerized Cognitive Training (CCT) Using EndeavorRxConflict RT (Incongruent Trial RT - Congruent Trial RT) on Flanker Task pre-intervention151.31Standard Deviation 188.11millisecondsClinicalTrials.gov
Change in Cognitive Control Capacity - Conflict RT FlankerComputerized Cognitive Training (CCT) Using EndeavorRxConflict RT (Incongruent Trial RT - Congruent Trial RT) on Flanker Task post-intervention311.82Standard Deviation 970.06millisecondsClinicalTrials.gov
Children's Depression Inventory (CDI) at Third TimepointComputerized Cognitive Training (CCT) Using EndeavorRx6.30Standard Deviation 6.48score on a scaleClinicalTrials.gov
Depressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R) at Third TimepointComputerized Cognitive Training (CCT) Using EndeavorRx23.27Standard Deviation 3.82score on a scaleClinicalTrials.gov
Cognitive Control Capacity - Overall Reaction Time (RT) StroopComputerized Cognitive Training (CCT) Using EndeavorRx982.60Standard Deviation 70.39millisecondsClinicalTrials.gov
Cognitive Control Capacity - Conflict RT StroopComputerized Cognitive Training (CCT) Using EndeavorRx58.45Standard Deviation 76.85millisecondsClinicalTrials.gov
Cognitive Control Capacity - Overall RT FlankerComputerized Cognitive Training (CCT) Using EndeavorRx597.31Standard Deviation 93.90millisecondsClinicalTrials.gov
Cognitive Control Capacity - Conflict RT FlankerComputerized Cognitive Training (CCT) Using EndeavorRx122.58Standard Deviation 39.81millisecondsClinicalTrials.gov

Participant flow 3

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource
Overall StudySTARTEDComputerized Cognitive Training (CCT) Using EndeavorRx20ClinicalTrials.gov
Overall StudyCOMPLETEDComputerized Cognitive Training (CCT) Using EndeavorRx19ClinicalTrials.gov
Overall StudyNOT COMPLETEDComputerized Cognitive Training (CCT) Using EndeavorRx1ClinicalTrials.gov

Adverse events 5

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource
otherMinor neck painMusculoskeletal and connective tissue disordersComputerized Cognitive Training (CCT) Using EndeavorRx1201ClinicalTrials.gov
otherCommon coldRespiratory, thoracic and mediastinal disordersComputerized Cognitive Training (CCT) Using EndeavorRx1201ClinicalTrials.gov
otherFluRespiratory, thoracic and mediastinal disordersComputerized Cognitive Training (CCT) Using EndeavorRx2202ClinicalTrials.gov
otherIncrease of depressive symptoms >25% on CDI from T1 to T2Psychiatric disordersComputerized Cognitive Training (CCT) Using EndeavorRx1201ClinicalTrials.gov
otherIncrease of depression symptoms >25% on CDI from T1 to T3Psychiatric disordersComputerized Cognitive Training (CCT) Using EndeavorRx2202ClinicalTrials.gov

Adverse event totals 3

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource
Total, all-cause mortalityComputerized Cognitive Training (CCT) Using EndeavorRx020ClinicalTrials.gov
Total, other adverse eventsComputerized Cognitive Training (CCT) Using EndeavorRx620ClinicalTrials.gov
Total, serious adverse eventsComputerized Cognitive Training (CCT) Using EndeavorRx020ClinicalTrials.gov

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Eriksen Flanker TaskPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)